A phase II trial of small-dose bortezomib, lenalidomide and dexamethasone (sVRD) as consolidation/maintenance therapy in patients with multiple myeloma

被引：0
|
作者：
Soushi Ibata
Tsutomu Sato
Hiroyuki Kuroda
Yasuhiro Nagamachi
Satoshi Iyama
Akihito Fujimi
Yusuke Kamihara
Yuichi Konuma
Masahiro Yoshida
Ayumi Tatekoshi
Akari Hashimoto
Hiroto Horiguchi
Kaoru Ono
Kazuyuki Murase
Kohichi Takada
Koji Miyanishi
Masayoshi Kobune
Yasuo Hirayama
Junji Kato
机构：
[1] Sapporo Medical University School of Medicine,Department of Medical Oncology and Hematology
[2] Steel Memorial Muroran Hospital,Gastroenterology and Hematology/Clinical Oncology, Internal Medicine
[3] Kiyota Hospital,Department of Hematology
[4] Oji General Hospital,Department of Hematology and Oncology
[5] Asahikawa Red Cross Hospital,Department of Hematology and Oncology
[6] Higashi Sapporo Hospital,Division of Internal Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2016年 / 78卷
关键词：
Multiple myeloma; Consolidation/maintenance; Bortezomib; Lenalidomide; Dexamethasone; VRD;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1041 / 1049
页数：8
相关论文
共 50 条
  • [1] A phase II trial of small-dose bortezomib, lenalidomide and dexamethasone (sVRD) as consolidation/maintenance therapy in patients with multiple myeloma
    Ibata, Soushi
    Sato, Tsutomu
    Kuroda, Hiroyuki
    Nagamachi, Yasuhiro
    Iyama, Satoshi
    Fujimi, Akihito
    Kamihara, Yusuke
    Konuma, Yuichi
    Yoshida, Masahiro
    Tatekoshi, Ayumi
    Hashimoto, Akari
    Horiguchi, Hiroto
    Ono, Kaoru
    Murase, Kazuyuki
    Takada, Kohichi
    Miyanishi, Koji
    Kobune, Masayoshi
    Hirayama, Yasuo
    Kato, Junji
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (05) : 1041 - 1049
  • [2] A PHASE 2 TRIAL OF SMALL-DOSE BORTEZOMIB, LENALIDOMIDE, AND DEXAMETHASONE (SVRD) AS CONSOLIDATION/MAINTENANCE THERAPY IN PATIENTS WITH MULTIPLE MYELOMA
    Sato, T.
    Kuroda, H.
    Nagamachi, Y.
    Iyama, S.
    Fujimi, A.
    Kamihara, Y.
    Konuma, Y.
    Yoshida, M.
    Ibata, S.
    Tatekoshi, A.
    Hashimoto, A.
    Horiguchi, H.
    Ono, K.
    Murase, K.
    Takada, K.
    Miyanishi, K.
    Kobune, M.
    Hirayama, Y.
    Kato, J.
    HAEMATOLOGICA, 2016, 101 : 792 - 793
  • [3] Consolidation therapy with bortezomib/lenalidomide/dexamethasone versus bortezomib/dexamethasone after a dexamethasone-based induction regimen in patients with multiple myeloma: A randomized phase III trial
    Fonseca, Rafael
    Rajkumar, S. Vincent
    CLINICAL LYMPHOMA & MYELOMA, 2008, 8 (05): : 315 - 317
  • [4] Consolidation and maintenance therapy with lenalidomide, bortezomib and dexamethasone (RVD) in high-risk myeloma patients
    Nooka, A. K.
    Kaufman, J. L.
    Muppidi, S.
    Langston, A.
    Heffner, L. T.
    Gleason, C.
    Casbourne, D.
    Saxe, D.
    Boise, L. H.
    Lonial, S.
    LEUKEMIA, 2014, 28 (03) : 690 - 693
  • [5] Consolidation and maintenance therapy with lenalidomide, bortezomib and dexamethasone (RVD) in high-risk myeloma patients
    A K Nooka
    J L Kaufman
    S Muppidi
    A Langston
    L T Heffner
    C Gleason
    D Casbourne
    D Saxe
    L H Boise
    S Lonial
    Leukemia, 2014, 28 : 690 - 693
  • [6] Bortezomib, Lenalidomide, and Dexamethasone (VRD) Consolidation and Lenalidomide Maintenance in Frontline Multiple Myeloma Patients: Updated Results of the IFM 2008 Phase II VRD Intensive Program
    Roussel, Murielle
    Robillard, Nelly
    Moreau, Philippe
    Benboubker, Lotfi
    Hulin, Cyrille
    Marit, Gerald
    Leleu, Xavier
    Pegourie, Brigitte
    Fruchart, Christophe
    Caillot, Denis
    Stoppa, Anne-Marie
    Facon, Thierry
    Wuilleme, Soraya
    Avet-Loiseau, Herve
    Attal, Michel
    BLOOD, 2011, 118 (21) : 816 - 817
  • [7] LENALIDOMIDE AS CONSOLIDATION/MAINTENANCE THERAPY IN MULTIPLE MYELOMA PATIENTS
    Gagliardi, A.
    Della Cioppa, P.
    Lucania, A.
    Villa, M. R.
    Esposito, M.
    Improta, S.
    Izzo, G. Nitrato
    Mastrullo, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 593 - 593
  • [8] Phase II Trials Evaluating Bortezomib/Lenalidomide/Dexamethasone in Multiple Myeloma
    不详
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (03): : 198 - 199
  • [9] Randomized phase III trial of consolidation therapy with bortezomib–lenalidomide–Dexamethasone (VRd) vs bortezomib–dexamethasone (Vd) for patients with multiple myeloma who have completed a dexamethasone based induction regimen
    S J Jacobus
    S V Rajkumar
    M Weiss
    A K Stewart
    E A Stadtmauer
    N S Callander
    L M Dreosti
    M Q Lacy
    R Fonseca
    Blood Cancer Journal, 2016, 6 : e448 - e448
  • [10] A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma
    Fuchida, Shin-ichi
    Sunami, Kazutaka
    Matsumoto, Morio
    Okumura, Hirokazu
    Murayama, Tohru
    Miyamoto, Toshihiro
    Otsuka, Eichi
    Fujishima, Naohito
    Izumi, Tohru
    Tamaki, Shigehisa
    Hiramatsu, Yasushi
    Kuroda, Yoshiaki
    Shimazaki, Chihiro
    Akashi, Koichi
    Harada, Mine
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (01) : 107 - 114
12345